| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
Form 4: Torti Frank, President and Vant Chair
Disposed of 392,052 shares (Other Transaction) ($16M) · Disposed of 392,048 shares (Other Transaction) ($16.4M) · Disposed of 392,043 shares (Other Transaction) ($15.9M) · 1 more |
| 12 Nov 2026 |
Form 4: Gline Matthew, Director
Disposed of 58,331 shares (Other Transaction) ($2.38M) · Disposed of 48,988 shares (Other Transaction) ($2.05M) · Disposed of 48,988 shares (Other Transaction) ($1.98M) · 1 more |
| 12 Nov 2026 |
Form 4: Sukhatme Mayukh, Director
Disposed of 59,034 shares (Other Transaction) ($2.41M) · Disposed of 53,205 shares (Other Transaction) ($2.22M) · Disposed of 53,205 shares (Other Transaction) ($2.15M) · 1 more |
| 12 Nov 2026 |
Form 4: Pulik Richard, CFO
Received 125,000 shares by exercise or conversion ($481K) · Sold 125,000 shares ($5.15M) · Received 127,365 shares by exercise or conversion ($490K) · 1 more |
| 12 Nov 2026 |
Form 4: Venker Eric, President & Immunovant CEO
Sold 187,943 shares ($7.62M) |
| 05 Nov 2026 |
Form 4: Venker Eric, President & Immunovant CEO
Sold 200,000 shares ($7.26M) |
| 30 Oct 2026 |
Form 4: Venker Eric, President & Immunovant CEO
Sold 200,000 shares ($7.32M) |
| 27 Oct 2026 |
Form 4: Oren Ilan, Director
Received 810 shares as a grant or award |
| 27 Oct 2026 |
Form 4: Epperly Melissa B,, Director
Received 513 shares as a grant or award · Gave up 116 shares to cover exercise price or tax ($4.23K) |
| 27 Oct 2026 |
Form 4: Momtazee James C, Director
Received 383 shares as a grant or award · Gave up 77 shares to cover exercise price or tax ($2.81K) |
| 22 Oct 2026 |
Form 4: Venker Eric, President & Immunovant CEO
Sold 200,000 shares ($7.02M) |
| 20 Oct 2026 |
Form 4: Sukhatme Mayukh, Director
Gave up 19,976 shares to cover exercise price or tax ($670K) |
| 20 Oct 2026 |
Form 4: Gline Matthew, Director
Gave up 34,638 shares to cover exercise price or tax ($1.16M) |
| 05 Oct 2026 |
Form 4: Roivant Sciences Ltd., Director · Arbutus Biopharma Corp
Returned 8,967,383 shares to the issuer ($44.8M) |
| 05 Oct 2026 |
Form 4: Epperly Melissa B,, Director
Received 17,750 shares by exercise or conversion ($79.2K) · Sold 17,750 shares ($641K) |
| 02 Oct 2026 |
Form 4: Gline Matthew, Director
Gave up 76,171 shares to cover exercise price or tax ($2.79M) |
| 02 Oct 2026 |
Form 4: Torti Frank, President and Vant Chair
Acquired 40,309 shares (Exercise Price / Tax Payment) ($1.47M) |
| 02 Oct 2026 |
Form 4: Sukhatme Mayukh, Director
Gave up 46,879 shares to cover exercise price or tax ($1.71M) |
| 02 Oct 2026 |
Form 4: Venker Eric, President & Immunovant CEO
Received 200,000 shares by exercise or conversion ($770K) · Sold 200,000 shares ($7.32M) |
| 22 Sep 2026 |
Form 4: Humes Jennifer, Chief Accounting Officer
Gave up 3,880 shares to cover exercise price or tax ($154K) |
Loading...